Comparing Stigma in Lung Cancer to Other Tobacco-Related Cancers: A Study from End Lung Cancer Now
Stigma in Lung Cancer and Tobacco-Related Cancers
Bharathi Muthusamy
Primary Investigator
Brief description of study
Detailed description of study
This is a descriptive, cross-sectional study, which will involve a one-time survey for patients with lung cancer (any histology), pancreatic adenocarcinoma, renal cell carcinoma, and urothelial carcinoma. The goal of the survey is to capture the patient’s demographics (age, gender, etc.), smoking status, and PCRS. ECOG performance status, stage of disease, point in treatment, and date of diagnosis will be collected from the EMR for each of the patients.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Lung Cancer, Pancreatic Adenocarcinoma, Eenal cell carcinoma, Urothelial carcinoma.
-
Age: 18 years - 100 years
-
Gender: All
Inclusion Criteria:
• 18 years or older at the time of informed consent
• Any stage of lung cancer (any histology), pancreatic adenocarcinoma, renal cell
carcinoma, and urothelial carcinoma.
• Able to read and write in English or Spanish.
• Able to provide written informed consent.
• No mental disability which would preclude completion of questionnaires.
Exclusion Criteria:
• Inability to provide informed consent.
• Inability to complete the survey.
• Primarily Spanish-speaking with any other cancer besides lung cancer.
• Patient with multiple primary cancers
This study investigates the stigma experienced by patients with lung cancer and other tobacco-related cancers, such as pancreatic adenocarcinoma, renal cell carcinoma, and urothelial carcinoma. A stigma is a mark of disgrace associated with a particular condition. The purpose of this study is to understand how stigma affects patients with these cancers by using a survey to collect information about demographics, smoking status, and other health details.
Participants will complete a one-time survey during their visit to the cancer clinic. The survey will gather information about the patient's age, gender, and smoking history. Medical records will provide additional details like the patient's health status and cancer stage. This information will help researchers understand the stigma in different cancer types.
- Who can participate: Adults aged 18 years or older with any stage of lung cancer, pancreatic adenocarcinoma, renal cell carcinoma, or urothelial carcinoma can participate. Participants must be able to read and write in English or Spanish and provide written consent.
- Study details: Participants will complete a one-time survey during their clinic visit. The survey will ask about demographics and smoking status. Additional health information will be collected from medical records.
- Study visits: The study requires 1 visit.